Apr 3, 02:30 PM

Grifols Family and Brookfield Resume Talks for Potential OPA Above €10.50 After 2024 Negotiations, Minority Shareholders Support

The Grifols family and Brookfield have resumed discussions regarding a potential takeover bid (OPA) for the pharmaceutical company Grifols. This follows previous negotiations in 2024 that did not result in an agreement. The Grifols family is reportedly seeking a bid price higher than the €10.50 proposed last November. Minority shareholders have expressed positive sentiments towards the potential OPA, provided it is not an exclusionary offer. The renewed talks have led to an uptick in Grifols' stock price as investors and analysts react to the new developments surrounding the company.

#Grifols #Brookfield

Written with ChatGPT (GPT-4o mini).

Sources

CincoDiascom@CincoDiascom
2 years ago
Los inversores y analistas han empezado a pronunciarse ante el nuevo escenario abierto en Grifols, una vez que Brookfield y los miembros de la familia fundadora han reconocido que han reanudado los contactos para retomar una posible opa conjunta. #farmacéutica #opa
Megabolsa@megabolsa
2 years ago
Noticias destacadas de empresas: Pharmamar, ArcelorMittal, Aena, IAG, ACS… https://t.co/frVx3U8s9N
Economía Digital@EconomiaED_
2 years ago
Los accionistas minoritarios de Grifols ven con buenos ojos la "probable" OPA de Brookfield si no es de exclusión https://t.co/awXtEwbGmz

Grifols Family and Brookfield Resume Talks for Potential OPA Above €10.50 After 2024 Negotiations, Minority Shareholders Support

Sources

Additional media

Similar Stories